DSpace at RU >

Browsing by Author Schouten, H.C.

Full Text	Issue Date	Title	Author(s)
	2011	Development and measurement of guideline-based indicators for patients with non-Hodgkin's lymphoma	Wennekes, L.; Ottevanger, P.B.; Raemaekers, J.M.M.; Schouten, H.C.; Kok, M.W. de, et al
	2010	Value of allogeneic versus autologous stem cell transplantation and chemotherapy in patients with myelodysplastic syndromes and secondary acute myeloid leukemia. Final results of a prospective randomized European Intergroup Trial.	Witte, T.J.M. de; Hagemeijer, A.; Suciu, S.; Belhabri, A.; Delforge, M., et al
	2010	Autologe stamceltransplantatie bij hematologische aandoeningen, 1980-2002	Beckers, M.M.; Verdonck, L.F.; Cornelissen, J.J.; Schattenberg, A.V.M.B.; Janssen, J.J.M., et al
	2009	Allogene stamceltransplantatie in Nederland	Schattenberg, A.V.M.B.; Schouten, H.C.; Verdonck, L.F.; Willemze, R.; Lelie, J. van der, et al
	2008	Thrombotic and infectious complications of central venous catheters in patients with hematological malignancies.	Boersma, R.S.; Jie, K.S.; Verbon, A.; Pampus, EC van; Schouten, H.C.
	2007	High-vs low-dose cytarabine combined with interferon alfa in patients with first chronic phase chronic myeloid leukemia : A prospective randomized phase III study	Deenik, W.; Holt, B. van der; Verhoef, G.E.; Schattenberg, A.V.M.B.; Verdonck, L.F., et al
	2005	Impact of three courses of intensified CHOP prior to high-dose sequential therapy followed by autologous stem-cell transplantation as first-line treatment in poor-risk, aggressive non-hodgkin's lymphoma: comparative analysis of Dutch-Belgian Hemato-Oncology Cooperative Group Studies 27 and 40.	Imhoff, G.W. van; Holt, B. van der; MacKenzie, M.A.; Veer, M.B. van 't; Wijermans, P.W., et al
	2005	Allogeneic stem cell transplantation for patients with acute myeloid leukemia or myelodysplastic syndrome who have chromosome 5 and/or 7 abnormalities.	Straaten, H.M. van der; Biezen, A. van; Brand, R.; Schattenberg, A.V.M.B.; Egeler, R.M., et al
	2005	Short intensive sequential therapy followed by autologous stem cell transplantation in adult Burkitt, Burkitt-like and lymphoblastic lymphoma.	Imhoff, G.W. van; Holt, B. van der; MacKenzie, M.A.; Ossenkoppele, G.J.; Wijermans, P.W., et al
	1997	Use of recombinant granulocyte-macrophage colony-stimulating factor during and after remission induction chemotherapy in patients aged 61 years and older with acute myeloid leukemia (AML): final report of AML-11, a phase III randomized study of the Leukemia Cooperative Group of European Organisation for the research and treatment of cancer (EORTC-LCG) and the Dutch Belgian Hemato-Oncology Cooperative Group (HOVON)	Lowenberg, B.; Suciu, S.; Archimbaud, E.; Ossenkoppele, G.J.; Verhoef, G.E.G., et al
	1997	Medical narratives in electronic medical records	Tange, H.J.; Hasman, A.; Vries Robbé, P.F., de; Schouten, H.C.
	1997	Double modulation of high-dose 5-fluorouracil with low-dose PALA and methotrexate: results of a randomized EORTC study	Blijham, G.H.; Wagener, D.J.T.; Schouten, H.C.
	1996	Age-specific differences in the diagnostics and treatment of cancer patients aged 50 years and older in the province of Limburg, the Netherlands	Rijke, J.M. de; Schouten, L.J.; Schouten, H.C.; Jager, J.J.; Koppejan, A.G., et al
	1995	Comparison of CHOP chemotherapy with autologous bone marrow transplantation for slowly responding patients with agressive non-Hodgkin's lymphoma	Verdonck, L.F.; Putten, W.L.J. van; Hagenbeek, A.; Schouten, H.C.; Sonneveld, P., et al